Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus

Int J Med Microbiol. 2015 Sep;305(6):501-4. doi: 10.1016/j.ijmm.2015.05.001. Epub 2015 May 16.

Abstract

The combination of baicalein (the active constituent of Scutellaria baicalensis) with penicillin G/amoxicillin showed potent synergy against 20 clinical penicillinase-producing Staphylococcus aureus strains including 10 isolates that were additionally methicillin-resistant (MRSA). The fractional inhibitory concentration (FIC) indices of penicillins+baiclein ranged from 0.14 to 0.38. Baicalein protected penicillins (penicillin G and amoxicillin) from penicillinase and increased the susceptibility of penicillinase-supplemented S. aureus ATCC 29213 in a dose-dependent manner. The inhibition of penicillinase activity by baicalein should be responsible for the synergism and protective effect. These findings offer us good evidence that the penicillins combined with baicalein showed potent synergistic activity against penicillinase-producing S. aureus and penicillinase-producing MRSA in vitro and might provide promising implications for clinical treatment of these bacterial infections.

Keywords: Baicalein; MRSA; Penicillinase; Penicillinase-producing Staphylococcus aureus; Penicillins; Synergism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Drug Synergism
  • Enzyme Inhibitors / pharmacology
  • Flavanones / pharmacology*
  • Humans
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Penicillinase / metabolism
  • Penicillins / pharmacology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / enzymology

Substances

  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • Flavanones
  • Penicillins
  • baicalein
  • Penicillinase